Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)

China flag China · Delayed Price · Currency is CNY
9.95
+0.24 (2.47%)
Jul 3, 2026, 3:04 PM CST
Market Cap3.15B -31.1%
Revenue (ttm)813.23M -25.4%
Net Income-317.84M
EPS-0.98
Shares Out 316.35M
PE Ration/a
Forward PEn/a
Dividend0.20 (2.01%)
Ex-Dividend DateMay 29, 2025
Volume4,154,200
Open9.52
Previous Close9.71
Day's Range9.52 - 10.00
52-Week Range8.93 - 17.46
Beta0.30
Analystsn/a
Price Targetn/a
Earnings DateAug 27, 2026

About SHE:002900

Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale chemical pharmaceutical preparations in China. The company offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, and body fluid balance infusion; and other products, including oxaliplatin for injection, calcium folinate for injection, hydroxylcamptothecine injection, tropisetron hydrochloride for injection, tropisetron hydrochloride and glucose injection, gabexate... [Read more]

Sector Healthcare
Founded 1996
Employees 2,086
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002900
Full Company Profile

Financial Performance

Financial Statements